Stem definition | Drug id | CAS RN |
---|---|---|
platelet aggregation inhibitors | 4113 | 150322-43-3 |
Dose | Unit | Route |
---|---|---|
10 | mg | O |
Property | Value | Reference |
---|---|---|
BDDCS (Biopharmaceutical Drug Disposition Classification System) | 2 | Benet LZ, Broccatelli F, Oprea TI |
EoM (Fraction excreted unchanged in urine) | 1 % | Benet LZ, Broccatelli F, Oprea TI |
Date | Agency | Company | Orphan |
---|---|---|---|
Feb. 24, 2009 | EMA | DAIICHI SANKYO EUROPE GMBH | |
July 10, 2009 | FDA | ELI LILLY AND CO | |
March 24, 2014 | PMDA | DAIICHI SANKYO COMPANY, LIMITED |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Thrombosis in device | 137.41 | 21.45 | 33 | 3488 | 2708 | 50598895 |
Myocardial infarction | 136.83 | 21.45 | 82 | 3439 | 88945 | 50512658 |
Vascular pseudoaneurysm | 103.12 | 21.45 | 23 | 3498 | 1361 | 50600242 |
Vascular stent stenosis | 94.20 | 21.45 | 18 | 3503 | 492 | 50601111 |
Acute myocardial infarction | 93.49 | 21.45 | 44 | 3477 | 29229 | 50572374 |
Gastrointestinal haemorrhage | 78.85 | 21.45 | 54 | 3467 | 73267 | 50528336 |
Coronary artery restenosis | 68.43 | 21.45 | 13 | 3508 | 344 | 50601259 |
Angina pectoris | 58.80 | 21.45 | 31 | 3490 | 26157 | 50575446 |
Angina unstable | 51.94 | 21.45 | 19 | 3502 | 6687 | 50594916 |
Haemorrhage | 51.89 | 21.45 | 37 | 3484 | 53404 | 50548199 |
Chest pain | 42.97 | 21.45 | 57 | 3464 | 176825 | 50424778 |
Coronary artery occlusion | 35.92 | 21.45 | 15 | 3506 | 7488 | 50594115 |
Phaeochromocytoma crisis | 35.68 | 21.45 | 7 | 3514 | 220 | 50601383 |
Platelet function test abnormal | 35.34 | 21.45 | 6 | 3515 | 82 | 50601521 |
Retroperitoneal haemorrhage | 34.57 | 21.45 | 11 | 3510 | 2545 | 50599058 |
Coronary artery stenosis | 32.65 | 21.45 | 12 | 3509 | 4277 | 50597326 |
Stent placement | 31.37 | 21.45 | 11 | 3510 | 3427 | 50598176 |
Somnambulism | 31.04 | 21.45 | 12 | 3509 | 4912 | 50596691 |
Myopathy | 29.95 | 21.45 | 14 | 3507 | 9125 | 50592478 |
Coronary artery disease | 29.79 | 21.45 | 21 | 3500 | 29705 | 50571898 |
Puncture site haemorrhage | 28.73 | 21.45 | 6 | 3515 | 259 | 50601344 |
Device occlusion | 28.69 | 21.45 | 12 | 3509 | 6011 | 50595592 |
Epistaxis | 28.03 | 21.45 | 28 | 3493 | 63926 | 50537677 |
Cerebral haemorrhage | 26.85 | 21.45 | 19 | 3502 | 27033 | 50574570 |
Acute coronary syndrome | 26.57 | 21.45 | 13 | 3508 | 9361 | 50592242 |
Cardiogenic shock | 25.51 | 21.45 | 15 | 3506 | 15584 | 50586019 |
Factor V inhibition | 25.08 | 21.45 | 5 | 3516 | 171 | 50601432 |
Coronary artery thrombosis | 24.91 | 21.45 | 7 | 3514 | 1060 | 50600543 |
Tachycardia paroxysmal | 22.92 | 21.45 | 5 | 3516 | 266 | 50601337 |
Coagulation factor V level decreased | 22.42 | 21.45 | 5 | 3516 | 295 | 50601308 |
Labelled drug-drug interaction medication error | 22.36 | 21.45 | 12 | 3509 | 10465 | 50591138 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Thrombosis in device | 345.64 | 17.60 | 91 | 7025 | 3073 | 29564338 |
Vascular stent thrombosis | 246.82 | 17.60 | 67 | 7049 | 2543 | 29564868 |
Vascular stent stenosis | 194.68 | 17.60 | 46 | 7070 | 984 | 29566427 |
Acute myocardial infarction | 160.67 | 17.60 | 115 | 7001 | 48323 | 29519088 |
Myocardial infarction | 128.76 | 17.60 | 145 | 6971 | 110151 | 29457260 |
Angina pectoris | 105.96 | 17.60 | 72 | 7044 | 27778 | 29539633 |
Chest pain | 105.49 | 17.60 | 132 | 6984 | 111841 | 29455570 |
Coronary artery restenosis | 81.66 | 17.60 | 23 | 7093 | 999 | 29566412 |
Angina unstable | 66.41 | 17.60 | 38 | 7078 | 10827 | 29556584 |
Haemorrhage | 64.25 | 17.60 | 66 | 7050 | 45006 | 29522405 |
Haemorrhage intracranial | 63.50 | 17.60 | 41 | 7075 | 14501 | 29552910 |
Gastrointestinal haemorrhage | 59.69 | 17.60 | 84 | 7032 | 79449 | 29487962 |
Coronary artery stenosis | 55.13 | 17.60 | 31 | 7085 | 8542 | 29558869 |
Labelled drug-drug interaction medication error | 52.39 | 17.60 | 34 | 7082 | 12125 | 29555286 |
Cardiac tamponade | 50.81 | 17.60 | 24 | 7092 | 4611 | 29562800 |
Coronary artery thrombosis | 40.52 | 17.60 | 16 | 7100 | 1989 | 29565422 |
Coronary artery occlusion | 40.50 | 17.60 | 27 | 7089 | 10067 | 29557344 |
Vascular pseudoaneurysm | 37.46 | 17.60 | 15 | 7101 | 1934 | 29565477 |
Haematoma | 36.73 | 17.60 | 36 | 7080 | 23176 | 29544235 |
Pulmonary alveolar haemorrhage | 32.90 | 17.60 | 20 | 7096 | 6360 | 29561051 |
Cerebral haemorrhage | 32.61 | 17.60 | 39 | 7077 | 31387 | 29536024 |
Pericardial haemorrhage | 31.58 | 17.60 | 15 | 7101 | 2916 | 29564495 |
Myocardial ischaemia | 31.41 | 17.60 | 28 | 7088 | 16000 | 29551411 |
Epistaxis | 30.71 | 17.60 | 49 | 7067 | 51655 | 29515756 |
Device occlusion | 30.00 | 17.60 | 18 | 7098 | 5590 | 29561821 |
Apnoeic attack | 29.43 | 17.60 | 8 | 7108 | 304 | 29567107 |
Upper gastrointestinal haemorrhage | 29.23 | 17.60 | 31 | 7085 | 21883 | 29545528 |
Acute coronary syndrome | 29.18 | 17.60 | 24 | 7092 | 12301 | 29555110 |
Intraventricular haemorrhage | 28.67 | 17.60 | 14 | 7102 | 2892 | 29564519 |
Obstructive shock | 28.06 | 17.60 | 5 | 7111 | 23 | 29567388 |
Coronary artery disease | 26.40 | 17.60 | 42 | 7074 | 44148 | 29523263 |
Abdominal symptom | 25.99 | 17.60 | 8 | 7108 | 474 | 29566937 |
Subdural haematoma | 24.73 | 17.60 | 26 | 7090 | 18167 | 29549244 |
Arterial restenosis | 23.08 | 17.60 | 5 | 7111 | 71 | 29567340 |
Peripheral arterial occlusive disease | 21.38 | 17.60 | 14 | 7102 | 5062 | 29562349 |
Cardiac failure | 21.35 | 17.60 | 54 | 7062 | 79233 | 29488178 |
Platelet function test abnormal | 21.19 | 17.60 | 5 | 7111 | 106 | 29567305 |
Procedural haemorrhage | 19.57 | 17.60 | 10 | 7106 | 2273 | 29565138 |
Coombs negative haemolytic anaemia | 19.53 | 17.60 | 5 | 7111 | 150 | 29567261 |
Non-cardiac chest pain | 19.37 | 17.60 | 12 | 7104 | 3945 | 29563466 |
Vessel puncture site haematoma | 19.16 | 17.60 | 4 | 7112 | 47 | 29567364 |
Melaena | 19.12 | 17.60 | 30 | 7086 | 31146 | 29536265 |
Toxicity to various agents | 19.04 | 17.60 | 9 | 7107 | 173652 | 29393759 |
Coronary artery perforation | 18.65 | 17.60 | 4 | 7112 | 54 | 29567357 |
Bladder tamponade | 18.05 | 17.60 | 6 | 7110 | 456 | 29566955 |
Melanaemia | 18.01 | 17.60 | 4 | 7112 | 64 | 29567347 |
MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
---|---|---|---|---|---|---|
Vascular stent thrombosis | 283.69 | 17.39 | 70 | 8599 | 3294 | 64486769 |
Thrombosis in device | 269.17 | 17.39 | 73 | 8596 | 4998 | 64485065 |
Acute myocardial infarction | 208.99 | 17.39 | 125 | 8544 | 69593 | 64420470 |
Myocardial infarction | 188.79 | 17.39 | 165 | 8504 | 165656 | 64324407 |
Gastrointestinal haemorrhage | 114.26 | 17.39 | 113 | 8556 | 132199 | 64357864 |
Vascular stent stenosis | 114.18 | 17.39 | 28 | 8641 | 1281 | 64488782 |
Vascular pseudoaneurysm | 102.83 | 17.39 | 31 | 8638 | 3093 | 64486970 |
Angina pectoris | 93.12 | 17.39 | 64 | 8605 | 45017 | 64445046 |
Chest pain | 87.09 | 17.39 | 131 | 8538 | 235849 | 64254214 |
Haemorrhage | 86.14 | 17.39 | 77 | 8592 | 79274 | 64410789 |
Coronary artery stenosis | 86.11 | 17.39 | 38 | 8631 | 11210 | 64478853 |
Coronary artery restenosis | 70.26 | 17.39 | 19 | 8650 | 1283 | 64488780 |
Labelled drug-drug interaction medication error | 69.74 | 17.39 | 41 | 8628 | 22021 | 64468042 |
Haemorrhage intracranial | 66.73 | 17.39 | 41 | 8628 | 23843 | 64466220 |
Angina unstable | 54.89 | 17.39 | 31 | 8638 | 15436 | 64474627 |
Coronary artery occlusion | 52.46 | 17.39 | 29 | 8640 | 13862 | 64476201 |
Coronary artery thrombosis | 51.58 | 17.39 | 18 | 8651 | 2851 | 64487212 |
Cerebral haemorrhage | 50.36 | 17.39 | 47 | 8622 | 51043 | 64439020 |
Epistaxis | 48.85 | 17.39 | 63 | 8606 | 98068 | 64391995 |
Intraventricular haemorrhage | 48.60 | 17.39 | 19 | 8650 | 4134 | 64485929 |
Acute coronary syndrome | 46.06 | 17.39 | 30 | 8639 | 19280 | 64470783 |
Haematoma | 44.53 | 17.39 | 42 | 8627 | 46208 | 64443855 |
Pulmonary alveolar haemorrhage | 44.26 | 17.39 | 23 | 8646 | 9715 | 64480348 |
Device occlusion | 43.88 | 17.39 | 23 | 8646 | 9890 | 64480173 |
Coronary artery disease | 43.72 | 17.39 | 47 | 8622 | 60386 | 64429677 |
Platelet function test abnormal | 38.31 | 17.39 | 8 | 8661 | 175 | 64489888 |
Upper gastrointestinal haemorrhage | 37.82 | 17.39 | 34 | 8635 | 35186 | 64454877 |
Stent placement | 36.85 | 17.39 | 17 | 8652 | 5554 | 64484509 |
Cardiac tamponade | 30.70 | 17.39 | 17 | 8652 | 8147 | 64481916 |
Cardiogenic shock | 30.35 | 17.39 | 29 | 8640 | 32398 | 64457665 |
Subdural haematoma | 29.95 | 17.39 | 27 | 8642 | 28027 | 64462036 |
Phaeochromocytoma crisis | 28.98 | 17.39 | 7 | 8662 | 300 | 64489763 |
Melaena | 27.60 | 17.39 | 35 | 8634 | 53513 | 64436550 |
Obstructive shock | 27.08 | 17.39 | 5 | 8664 | 56 | 64490007 |
Cardiac failure | 26.09 | 17.39 | 56 | 8613 | 132317 | 64357746 |
Myocardial ischaemia | 26.06 | 17.39 | 23 | 8646 | 23228 | 64466835 |
Somnambulism | 25.85 | 17.39 | 13 | 8656 | 5128 | 64484935 |
Thrombotic cerebral infarction | 25.85 | 17.39 | 7 | 8662 | 475 | 64489588 |
Peripheral arterial occlusive disease | 24.78 | 17.39 | 14 | 8655 | 6973 | 64483090 |
Apnoeic attack | 24.67 | 17.39 | 7 | 8662 | 564 | 64489499 |
Thrombosis | 24.24 | 17.39 | 38 | 8631 | 70604 | 64419459 |
Abdominal symptom | 23.62 | 17.39 | 7 | 8662 | 658 | 64489405 |
Factor V inhibition | 23.02 | 17.39 | 6 | 8663 | 351 | 64489712 |
Pericardial haemorrhage | 22.40 | 17.39 | 11 | 8658 | 4125 | 64485938 |
Subarachnoid haemorrhage | 22.20 | 17.39 | 19 | 8650 | 18419 | 64471644 |
Post procedural haemorrhage | 21.83 | 17.39 | 16 | 8653 | 12415 | 64477648 |
Vascular stent occlusion | 21.01 | 17.39 | 5 | 8664 | 201 | 64489862 |
Bladder tamponade | 20.71 | 17.39 | 6 | 8663 | 521 | 64489542 |
Melanaemia | 20.28 | 17.39 | 4 | 8665 | 65 | 64489998 |
Cerebral infarction | 19.85 | 17.39 | 26 | 8643 | 41018 | 64449045 |
Product administration error | 19.11 | 17.39 | 21 | 8648 | 27622 | 64462441 |
Electrocardiogram ST segment elevation | 19.10 | 17.39 | 12 | 8657 | 7247 | 64482816 |
Myopathy | 18.84 | 17.39 | 17 | 8652 | 17663 | 64472400 |
Haematuria | 18.66 | 17.39 | 31 | 8638 | 60440 | 64429623 |
Hepatitis acute | 18.62 | 17.39 | 15 | 8654 | 13374 | 64476689 |
Coombs negative haemolytic anaemia | 18.30 | 17.39 | 5 | 8664 | 351 | 64489712 |
Retroperitoneal haematoma | 18.23 | 17.39 | 10 | 8659 | 4701 | 64485362 |
Blood loss anaemia | 18.13 | 17.39 | 15 | 8654 | 13877 | 64476186 |
Retroperitoneal haemorrhage | 17.93 | 17.39 | 10 | 8659 | 4858 | 64485205 |
Tachycardia paroxysmal | 17.82 | 17.39 | 5 | 8664 | 387 | 64489676 |
Shock haemorrhagic | 17.61 | 17.39 | 16 | 8653 | 16775 | 64473288 |
Ocular retrobulbar haemorrhage | 17.49 | 17.39 | 4 | 8665 | 135 | 64489928 |
None
Source | Code | Description |
---|---|---|
ATC | B01AC22 | BLOOD AND BLOOD FORMING ORGANS ANTITHROMBOTIC AGENTS ANTITHROMBOTIC AGENTS Platelet aggregation inhibitors excl. heparin |
FDA PE | N0000008832 | Decreased Platelet Aggregation |
MeSH PA | D006401 | Hematologic Agents |
MeSH PA | D010975 | Platelet Aggregation Inhibitors |
FDA EPC | N0000182142 | P2Y12 Platelet Inhibitor |
FDA MoA | N0000182143 | P2Y12 Receptor Antagonists |
CHEBI has role | CHEBI:35554 | cardiovascular agent |
CHEBI has role | CHEBI:50433 | platelet glycoprotein-IIb/IIIa receptor antagonists |
CHEBI has role | CHEBI:68563 | ADP receptor subtype P2Y12 antagonists |
CHEBI has role | CHEBI:50266 | Prodrugs |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Prevention of recurrence of ischemic cerebrovascular disease | indication | 62914000 | DOID:6713 |
Acute coronary syndrome | indication | 394659003 | |
Percutaneous coronary intervention | indication | 415070008 | |
Myocardial Reinfarction Prevention | indication | ||
Intracranial hemorrhage | contraindication | 1386000 | |
Acute hemorrhage | contraindication | 8573003 | |
Acute peptic ulcer with hemorrhage | contraindication | 12274003 | |
Low blood pressure | contraindication | 45007003 | |
Hepatic failure | contraindication | 59927004 | |
Blood coagulation disorder | contraindication | 64779008 | DOID:1247 |
Aortocoronary artery bypass graft | contraindication | 67166004 | |
Thrombotic thrombocytopenic purpura | contraindication | 78129009 | DOID:10772 |
Cerebrovascular accident | contraindication | 230690007 | |
Transient ischemic attack | contraindication | 266257000 | DOID:224 |
Surgical procedure | contraindication | 387713003 | |
Traumatic injury | contraindication | 417746004 | |
Significant Bleeding | contraindication |
None
None
Dissociation level | Dissociation constant | Type (acidic/basic) |
---|---|---|
pKa1 | 5.53 | Basic |
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
P2Y purinoceptor 12 | GPCR | ANTAGONIST | UNKNOWN | CHEMBL |
ID | Source |
---|---|
4029056 | VUID |
N0000179815 | NUI |
D05597 | KEGG_DRUG |
389574-19-0 | SECONDARY_CAS_RN |
4029056 | VANDF |
4029068 | VANDF |
C2683417 | UMLSCUI |
CHEBI:87715 | CHEBI |
CHEMBL1201772 | ChEMBL_ID |
DB06209 | DRUGBANK_ID |
CHEMBL1201773 | ChEMBL_ID |
D000068799 | MESH_DESCRIPTOR_UI |
6918456 | PUBCHEM_CID |
7562 | IUPHAR_LIGAND_ID |
8503 | INN_ID |
34K66TBT99 | UNII |
613391 | RXNORM |
166281 | MMSL |
261080 | MMSL |
26287 | MMSL |
39620 | MMSL |
d07409 | MMSL |
012994 | NDDF |
012995 | NDDF |
443129001 | SNOMEDCT_US |
443312008 | SNOMEDCT_US |
735166002 | SNOMEDCT_US |
Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
---|---|---|---|---|---|---|---|---|
Effient | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0002-5121 | TABLET, FILM COATED | 5 mg | ORAL | NDA | 32 sections |
Effient | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0002-5123 | TABLET, FILM COATED | 10 mg | ORAL | NDA | 32 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0378-5185 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 29 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0378-5186 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 29 sections |
PRASUGREL | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0440-0604 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 29 sections |
PRASUGREL | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0440-0605 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 29 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16729-272 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 27 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 16729-273 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 43817-239 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 27 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 43817-240 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-4118 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 26 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 50090-5169 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-247 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 27 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-247 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 27 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-248 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-248 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-444 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 29 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-445 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 29 sections |
Effient | HUMAN PRESCRIPTION DRUG LABEL | 1 | 54868-6238 | TABLET, FILM COATED | 10 mg | ORAL | NDA | 28 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 60505-4642 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 27 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 60505-4643 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 27 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 65162-001 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 26 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 65162-001 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 26 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 65162-002 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 26 sections |
Prasugrel | HUMAN PRESCRIPTION DRUG LABEL | 1 | 65162-002 | TABLET, FILM COATED | 10 mg | ORAL | ANDA | 26 sections |
Effient | HUMAN PRESCRIPTION DRUG LABEL | 1 | 65597-601 | TABLET, COATED | 5 mg | ORAL | NDA | 33 sections |
Effient | HUMAN PRESCRIPTION DRUG LABEL | 1 | 65597-601 | TABLET, COATED | 5 mg | ORAL | NDA | 33 sections |
Effient | HUMAN PRESCRIPTION DRUG LABEL | 1 | 65597-602 | TABLET, COATED | 10 mg | ORAL | NDA | 33 sections |
Effient | HUMAN PRESCRIPTION DRUG LABEL | 1 | 65597-602 | TABLET, COATED | 10 mg | ORAL | NDA | 33 sections |
Prasugrel | Human Prescription Drug Label | 1 | 65862-829 | TABLET, FILM COATED | 5 mg | ORAL | ANDA | 27 sections |